Thomas Curfman, MD
Neurology · Fort Wayne, INNPI 1184621641
Payments from drug & device makers
Across 69 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- Medtronic$112
- Supernus Pharmaceuticals, Inc.$106
- Nevro Corp.$98
- Pfizer$84
- Novartis$70
- plus $366 from 16 others
What the payments were for
- Food & beverage$1,22899%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $405 |
| Medtronic | 3 | $112 |
| Supernus Pharmaceuticals, Inc. | 5 | $106 |
| Nevro Corp. | 2 | $98 |
| Pfizer | 4 | $84 |
| Novartis | 3 | $70 |
| Sunovion Pharmaceuticals Inc. | 7 | $56 |
| Greenwich Biosciences, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $28 |
| Acadia Pharmaceuticals Inc | 2 | $27 |
| UCB, Inc. | 2 | $25 |
| AstraZeneca | 1 | $25 |
| GE HealthCare | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| EMD Serono, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Zogenix Inc. | 1 | $13 |
How this compares
$1,241 in reported general payments places this provider in the 40th percentile of 308 neurology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex Pen (4 Pack)Interferon Beta-1a | 13 | $123,392 |
| RexultiBrexpiprazole | 11 | $15,789 |
| Lacosamide | 18 | $3,657 |
| Levetiracetam ErLevetiracetam | 12 | $2,267 |
| Levetiracetam | 18 | $1,866 |
| Tetrabenazine | 11 | $1,835 |
| Oxcarbazepine | 19 | $1,608 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 38 | $1,057 |
| Lamotrigine | 35 | $713 |
| Baclofen | 11 | $650 |
| Topiramate | 22 | $582 |
| Primidone | 21 | $426 |
| Donepezil Hcl | 38 | $305 |
| Clonazepam | 14 | $178 |
| Sertraline Hcl | 20 | $141 |
Paid to pharmacies, not to this prescriber.
Other neurology in Fort Wayne
- Ajay GuptaFort Wayne$2.5M
- James StevensFort Wayne$1.5M
- Andrea HallerFort Wayne$793K
- Marlene BultemeyerFort Wayne$525K
- Paul LaterFort Wayne$132K
- Christopher VachonFort Wayne$114K
- Thomas BanasFort Wayne$91K
- Fen Lei ChangFort Wayne$47K
- Kristi GeorgeIndianapolis$10.8M
- Craig HerrmanIndianapolis$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.